Cover image not available

Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth fact

Nigel Fleeman

Publication Data

Title Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth fact
Author Nigel Fleeman
Contributors NIHR Health Technology Assessment Programme, NIHR Evaluation, Trials and Studies Coordinating Centre
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2011
Publication location Perth
Language English

Topics

Lapatinib :: Evaluation
Lapatinib :: Cost effectiveness
Trastuzumab :: Evaluation
Trastuzumab :: Cost effectiveness
Breast cancer :: Treatment :: Evaluation

Catalogue Data

OBNB ID GBB210672
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99449061

ISBD

P1053 xvi, 100 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth fact by Nigel Fleeman. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2011. Publication and catalogue information, links to buy online and reader comments.